AACR Annual Meeting 2022
April 8-13, 2022
See the Latest Updates From Novartis
Explore our congress-specific scientific presentations and symposia as well as our pipeline, clinical trials, disease areas/platforms, and approved products.
Featured Congresses
Featured Congresses
Disease Areas & Platforms
Novartis is reimagining cancer and blood disorders through education, research, and innovation.
Pipeline
View our broad research portfolio with innovative compounds in all phases of development.
Our 4 Bold Approaches to Cancer Treatment
Our 4 Bold Approaches to Cancer Treatment
Reimagining Cancer & Blood Disorders
Novartis is uniquely positioned to lead the next wave of novel investigational treatments through our strengths in 4 therapeutic platforms: targeted therapy, radioligand therapy, cell & gene therapy, and immunotherapy.
